| Detected | Trial | Change |
|---|---|---|
| 2026-08-01 | NCT06333483 Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus… |
Enrollment closed, study ongoing |
| 2026-08-01 | NCT06333483 Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus… |
Enrollment reduced: 18 -> 16 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07053800 | Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus… | Lupus Nephritis | Recruiting |
| NCT03628612 | Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells | Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy | Enrolling by Invitation |
| Phase 1/2 | |||
| NCT04404660 | A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory… | Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| Phase 1 | |||
| NCT06173518 | A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or… | Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT07139743 | Obe-cel in Refractory Progressive Forms of Multiple Sclerosis | Progressive Multiple Sclerosis | Recruiting |
| NCT06333483 | Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus… | Systemic Lupus Erythematosus | Active, Not Recruiting |